Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,806 | 0 | 0 | 0 | 80,030 |
| Marketable Securities | 253,458 | 0 | 0 | 0 | 58,952 |
| Other current assets | 0 | 0 | 0 | 0 | 5,281 |
| TOTAL | $384,467 | $0 | $0 | $0 | $144,263 |
| Non-Current Assets | |||||
| PPE Net | 46,775 | N/A | N/A | N/A | 29,727 |
| Investments And Advances | 33,731 | 0 | 0 | 0 | 0 |
| Intangibles | 199,822 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 65,501 | 0 | 0 | 0 | 202,121 |
| TOTAL | $345,829 | $N/A | $N/A | $N/A | $231,848 |
| Total Assets | $730,296 | $0 | $0 | $0 | $415,192 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,253 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 25,486 | 0 | 0 | 0 | 17,981 |
| TOTAL | $31,451 | $0 | $0 | $0 | $19,323 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,120,029 | 0 | 0 | 0 | 492,052 |
| TOTAL | $1,120,029 | $N/A | $N/A | $N/A | $492,052 |
| Total Liabilities | $1,151,480 | $0 | $0 | $0 | $557,734 |
| Shareholders' Equity | |||||
| Common Shares | 2 | 0 | 0 | 0 | 1 |
| Retained earnings | -429,432 | 0 | 0 | 0 | -144,127 |
| Other shareholders' equity | 30 | 0 | 0 | 0 | 26 |
| TOTAL | $-421,184 | $0 | $0 | $0 | $-142,542 |
| Total Liabilities And Equity | $730,296 | $0 | $0 | $0 | $415,192 |